|  | Male (N = 42) | Female (N = 57) | Total (N = 99) |
---|---|---|---|---|
Zagazig Severity | None (< 10) | 34 (81.0%) | 35 (61.4%) | 69 (69.7%) |
 | Mild (10-19) | 6 (14.2%) | 18 (31.6%) | 25 (25.3%) |
 | Moderate (20-29) | 1 (2.4%) | 4 (7.0%) | 4 (4%) |
 | Severe (≥30) | 1 (2.4%) | 0 (0.0%) | 1 (1%) |
PHQ Severity | None (< 5) | 33 (78.6%) | 29 (50.9%) | 62 (62.6%) |
 | Mild (5-9) | 5(11.9%) | 20 (35.1%) | 25 (25.3%) |
 | Moderate (10-14) | 3 (7.1%) | 7 (12.3%) | 10 (10.1%) |
 | Moderate to severe (15-19) | 0(0.0%) | 1 (1.8%) | 1 (1%) |
 | Severe (≥20) | 1 (2.4%) | 0 (0.0%) | 1 (1%) |